Incretin

Lilly Releases Zepbound Single-Dose Vials for Adults Living with Obesity

August 31, 2024 · Orlando, Florida Local News

Eli Lilly and Company released Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials for adults living with obesity, and announced the medicines are available for self-pay for…

Next Gen Weight Loss Drugs Are Coming for Ozempic’s Throne

June 25, 2024 · Gadgets

The future of weight loss is fast approaching. At a recent scientific conference, drug companies showed off a variety of next-generation drugs for both obesity and type 2…